Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Unknown status
CT.gov ID
NCT00831948
Collaborator
(none)
20
1

Study Details

Study Description

Brief Summary

Mitochondrial diseases are a heterogeneous group caused by genetic defects in mitochondrial DNA or in nuclear genes. POLG is the most frequently involved gene in mtDNA instability diseases resulting in mtDNA multiple deletion and/or depletion. It encodes the DNA polymerase gamma (POLγ), the only known DNA polymerase found in mammalian mitochondria. Mutations in POLG could explain 45% of familial progressive external ophtalmoplegia associated with multiple mtDNA deletions. However, in more than 70%, the analysis of the genes involved in mtDNA instability remains unsuccessful.

To date, these genes are screened by sequencing methods that are not able to detect large-scale rearrangements. In order to detect possible large-scale rearrangements, the investigators propose to develop a new assay based on QMPSF (Quantitative Multiplex PCR of Short fluorescent Fragments) able to detect exon deletions and duplications. the investigators propose to screen the POLG gene by QMPSF in at least twenty patients with either no mutation or only one mutation detected in POLG and no mutation in other genes such as TWINKLE and ANT1.

This study would allow the investigators to know if large-scale rearrangements occur in the POLG gene and to estimate their frequency in patients with mtDNA instability. These data are important to know if the sequencing analysis of POLG should be completed by the screening for partial deletions and duplications to ensure an accurate molecular diagnosis of these syndromes. Moreover, this method could be extended to ANT1 and TWINKLE genes.

Condition or Disease Intervention/Treatment Phase
  • Genetic: mitochondrial DNA mutations diagnosis

Study Design

Study Type:
Observational
Anticipated Enrollment :
20 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Identification of Large-Scale Mutations of POLG Gene by QMPSF in Patients With Mitochondrial DNA Instability.
Study Start Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Mitochondrial disease

Patients already diagnosed for mitochondrial pathology without mtDNA mutations yet detected by current diagnostic techniques

Genetic: mitochondrial DNA mutations diagnosis
Identification of large-scale mutations of POLG gene by QMPSF in patients with mitochondrial DNA instability.

Outcome Measures

Primary Outcome Measures

  1. Improving the diagnosis of mitochondrial pathology [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients already diagnosed for mitochondrial pathology without mtDNA mutations yet detected by current diagnostic techniques

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Universitaire de Nice- Hôpital ARCHET 2 -Laboratoire de Génétique Médicale Nice France 06200

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nice

Investigators

  • Principal Investigator: Cécile ROUZIER, MD, Centre Hospitalier Universitaire

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00831948
Other Study ID Numbers:
  • 08-CIR-02- Dr ROUZIER
First Posted:
Jan 29, 2009
Last Update Posted:
Jan 29, 2009
Last Verified:
Jan 1, 2009
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2009